Literature DB >> 8525021

Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury.

L J Boersma1, E M Damen, R W de Boer, S H Muller, R A Valdés Olmos, N van Zandwijk, J V Lebesque.   

Abstract

PURPOSE: To predict the pulmonary function 3-4 months after irradiation for malignant lymphoma from the three-dimensional (3-D) dose distribution.
METHODS: Dose-effect relations for the relative reduction of local perfusion (Q) and local ventilation (V), were calculated in 25 patients, using correlated SPECT (Single Photon Emission Computed Tomography) and CT data. By combining the 3-D dose distribution of an individual patient with the dose-effect relations averaged over all patients, the average reduction of local Q and V (i.e., the overall response parameters) in the whole lung was estimated for each patient. Correlation coefficients were calculated between these overall response parameters and the change in standard lung function tests. In addition, the relation between the overall response parameters and the incidence of radiation pneumonitis was determined.
RESULTS: The overall response parameter for perfusion was correlated with the change in standard lung function tests, with correlation coefficients varying between 0.53 (p = 0.007) and 0.71 (p < 0.001) for the change of Vital Capacity and Forced Expiratory Volume at 1 s, respectively. For the overall response parameter for ventilation similar correlations were observed. Four out of the 25 patients developed radiation pneumonitis; in these four patients the overall response parameter for perfusion was on average somewhat higher (13.2 +/- 1.4% (1 standard error of the mean)) than in patients without radiation pneumonitis (10.5 +/- 1.0%), but this difference was not significant. A higher incidence of radiation pneumonitis was observed for larger values of the overall response parameter for perfusion; in patient groups with an overall response parameter for perfusion of 0-5%, 5-10%, 10-15%, and 15-20%, the incidence of radiation pneumonitis was 0 (0/1), 10 (1/10), 13 (1/8) and 33% (2/6), respectively.
CONCLUSION: By combining the 3-D dose distribution with the average dose-effect relations for local perfusion or ventilation, an overall response parameter can be calculated prior to irradiation, which is predictive for the radiation-induced change in the overall pulmonary function, and possibly for the incidence of radiation pneumonitis, in this group of patients.

Entities:  

Mesh:

Year:  1995        PMID: 8525021     DOI: 10.1016/0167-8140(95)01580-a

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Quantitative study of lung perfusion SPECT scanning and pulmonary function testing for early radiation-induced lung injury in patients with locally advanced non-small cell lung cancer.

Authors:  Wei Zhang; Jiezhong Wang; Mingdeng Tang; Jianji Pan; Penggang Bai; Duanyu Lin; Feiyu Qian; Fengjie Lin; Xueqin Yang; Shengli Zhang
Journal:  Exp Ther Med       Date:  2012-01-31       Impact factor: 2.447

2.  Functional dose-volume histograms for predicting radiation pneumonitis in locally advanced non-small cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy.

Authors:  Dongqing Wang; Baosheng Li; Zhongtang Wang; Jian Zhu; Hongfu Sun; Jian Zhang; Yong Yin
Journal:  Exp Ther Med       Date:  2011-06-29       Impact factor: 2.447

3.  Comparison of the helical tomotherapy against the multileaf collimator-based intensity-modulated radiotherapy and 3D conformal radiation modalities in lung cancer radiotherapy.

Authors:  P Mavroidis; C Shi; G A Plataniotis; M G Delichas; B Costa Ferreira; S Rodriguez; B K Lind; N Papanikolaou
Journal:  Br J Radiol       Date:  2010-09-21       Impact factor: 3.039

4.  CT density in lung cancer patients after radiotherapy sensitized by metoclopramide. A subgroup analysis of a randomized trial.

Authors:  Einar Dale; Vanja Hårsaker; Doris T Kristoffersen; Oyvind Bruland; Dag R Olsen
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

5.  Association between RT-induced changes in lung tissue density and global lung function.

Authors:  Jinli Ma; Junan Zhang; Sumin Zhou; Jessica L Hubbs; Rodney J Foltz; Donna R Hollis; Kim L Light; Terence Z Wong; Christopher R Kelsey; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-10       Impact factor: 7.038

6.  Liver function after irradiation based on computed tomographic portal vein perfusion imaging.

Authors:  Yue Cao; Charlie Pan; James M Balter; Joel F Platt; Isaac R Francis; James A Knol; Daniel Normolle; Edgar Ben-Josef; Randall K Ten Haken; Theodore S Lawrence
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-12       Impact factor: 7.038

7.  Local and Global Function Model of the Liver.

Authors:  Hesheng Wang; Mary Feng; Andrew Jackson; Randall K Ten Haken; Theodore S Lawrence; Yue Cao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-09       Impact factor: 7.038

8.  Functional and biologic metrics for predicting radiation pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.

Authors:  Dongqing Wang; Jingyu Zhu; Jinbo Sun; Baosheng Li; Zhongtang Wang; Ling Wei; Yong Yin; Hongfu Sun; Zheng Fu; Xingguo Zhang; Zongwei Huo
Journal:  Clin Transl Oncol       Date:  2012-07-20       Impact factor: 3.405

9.  Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional Damage.

Authors:  Daniel Rocky Owen; Phillip S Boonstra; Benjamin L Viglianti; James M Balter; Matthew J Schipper; William C Jackson; Issam El Naqa; Shruti Jolly; Randall K Ten Haken; Feng-Ming Spring Kong; Martha M Matuszak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-01       Impact factor: 7.038

10.  Transforming growth factor-beta-1 is a serum biomarker of radiation-induced pneumonitis in esophageal cancer patients treated with thoracic radiotherapy: preliminary results of a prospective study.

Authors:  Jingxia Li; Shuangfeng Mu; Lixiang Mu; Xiaohui Zhang; Ranran Pang; Shegan Gao
Journal:  Onco Targets Ther       Date:  2015-05-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.